BRAF and neoplasm: Some authors claim age and male sex to be strong, continuous, and independent mortality risk factors in patients with BRAF V600E mutation, but not in patients with wild-type BRAF [9,12], others do not report a negative prognostic impact of BRAF V600E mutation status on survival [13], or for aggressive tumor behavior in conventional and follicular variants of PTC [14,15].